This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Insulin Resistance Atherosclerosis Study (IRAS)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005135
First received: May 25, 2000
Last updated: August 5, 2016
Last verified: April 2009
  Purpose
To conduct a multicenter study of the relationship between insulin resistance and cardiovascular disease (CVD) and its risk factors in a tri-ethnic (African-American, Hispanic, and non-Hispanic white) population aged 40 to 69 years at baseline. Also, to identify the genetic determinants of insulin resistance and visceral adiposity.

Condition
Cardiovascular Diseases Atherosclerosis Diabetes Mellitus Heart Diseases Obesity Insulin Resistance

Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1991
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005135

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Richard Bergman University of Southern California
OverallOfficial: Donald Bowden Wake Forest University
OverallOfficial: Michael Bryer-Ash University of California, Los Angeles
OverallOfficial: Steven Haffner University of Texas
OverallOfficial: Jill Norris University of Colorado, Denver
OverallOfficial: Marian Rewers University of Colorado Health Science Center
OverallOfficial: Mohammed Saad University of Southern California
OverallOfficial: Joseph Selby Kaiser Foundation Research Institute
OverallOfficial: Lynne Wagenknecht Wake Forest University
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005135     History of Changes
Other Study ID Numbers: 1005
U01HL047890 ( US NIH Grant/Contract Award Number )
Study First Received: May 25, 2000
Last Updated: August 5, 2016

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Atherosclerosis
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Hyperinsulinism

ClinicalTrials.gov processed this record on June 28, 2017